A Phase 1, Randomized, Open-Label, Crossover Study to Evaluate the Food-Effect of Single Oral Dose Administration of TAK-536TCH Final Formulation Tablet in Healthy Adult Male Subjects
Phase of Trial: Phase I
Latest Information Update: 24 May 2016
At a glance
- Drugs Amlodipine/azilsartan/hydrochlorothiazide (Primary)
- Indications Essential hypertension
- Focus Pharmacokinetics
- Sponsors Takeda
- 03 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 26 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 30 Jan 2015 New trial record